Health Minister Robert F. Kennedy Junior for extensive discounts in federal health agencies, including the Food and Drug Administration, which will eliminate repeated services and paper motives.
But in interviews with more than ten FDA employees, the current and former drug administration, a different image of the long -term effects of workers’ layoffs that eventually reduce the agency’s workforce by 20 percent. Among them are experts who have stored a maze of laws to determine whether an expensive drug can be sold as a low -cost year; Laboratory scientists who have tested food and drugs for deadly pollutants or bacteria; Veterinary band specialists investigate the transmission of bird flu; Researchers who monitored televised ads for false claims about prescribed medications.
In many fields of food and drug management (FDA), there are still employees to treat salary statements, to provide retirement or paper layoffs and help inspectors abroad who are at risk of reducing agency credit cards. Even the Agency Library, where researchers and experts relied on the medical magazines’ contributions that were now closed.
The new commissioner in the FDA, Dr. Marti Macari, appeared on his long -awaited appearance at Maryland headquarters on Wednesday. He gave a speech that defines extensive problems in the health care system, including the rise in chronic diseases. The employees have not been given an official opportunity to ask questions.
About 3,500 employees in the FDA will lose their jobs under discounts. A spokesman for the health and humanitarian services did not answer the questions.
When the Trump administration carried out its first tour of the discounts to the Food and Drug Administration in February, it encouraged teams of scientists who did carefully to ensure the safety of surgical robots and devices that put insulin in children with diabetes. Some layoffs and retreats, which were described by the former food and drug administration officials as arbitrary, were reflected.
Dr. David Kisler, the former agency commissioner and White House advisor, said that the epidemic responded during the era of President Biden, that the last round of workers related to decades of experience and decisive knowledge from the agency.
He said: “I think he is destroyed, random, not thinking about it and chaotic.” “I think they need to be canceled.”
It is still not certain whether the administration will be restored to any of the lost jobs. In the interviews, 15 current and former employees, some of whom spoke on the condition that their identity is not disclosed, described for fear of losing the job or revenge, their layoffs and their expected effects on food, medicines and medical supplies in the country.
Weaker screens for food safety
The agency canceled scientists in many product safety laboratories, including a laboratory near San Francisco, tested food. These cuts come in addition to the recent disposal of the main food safety committee and reduce the financing of government food inspectors.
San Francisco Laboratory has verified the deadly bacteria on food to support inspections and investigations and has experience in discovering heavy metals and toxic elements. He – she It was also analyzed Food colors and additions – a declared priority for the new management.
Another victim of the Food Department included almost all employees in the International Policy and Participation Office. She exchanged data with other countries to get rid of the outbreaks of foods transmitted by food that was discovered abroad before the products reached the United States.
“If Canada has a great outbreak, will they notify the Food and Drug Administration and exchange this information?” Susan Main, a senior food and drug official (FDA) and an auxiliary professor of epidemics at Yale University. “And if so, who would have occurred?
The International Food Bureau has worked with developed countries to exchange inspection records for food manufacturing factories abroad-so that more federal dollars can investigate food treatments in developing countries. It is still unclear whether anyone will pick up the work of the closed sections.
Funding drug review at risk
The FDA is widely funded by the industries that organize it, including medications, medical devices and tobacco. Industry fees, which represent about half of the agency’s budget, are paid under the conditions that are negotiated between the agency and industries. Conventions are monitored and approved by Congress.
Many, including Mr. Kennedy, have criticized as a means of these industries to use the unjustified effect, the agreements do not obligate the fed and drug administration employees to agree to new drugs. However, the employees must fulfill the strict final deadlines during the approval process.
These acute discounts can expose user fee of up to hundreds of millions of dollars. Losses can hit the “trigger” in the law that will completely close the fees.
This may not leave almost anyone to review the applications of long drug approval or to declare new cancer and rare diseases.
Although the Commercial Pharmaceutical Industry Association refused PRAMA, he asked for the interview, but Alex Shrefar, the first vice president of public affairs, said that the major changes in the Food and Drug Administration “raises questions about the agency’s ability to fulfill its mission to bring new innovative drugs to patients.”
It is more complicated, the bills and injection employees who managed the industry fee program and officials who negotiated conditions on the fees were delivered.
Few check on drug safety
Other laboratories that were discharged included one in Chicago, where scientists studied food packaging and how chemicals migrated to food.
Almost all employees were laid off in drug safety Laboratory in Detroit That supported the work of the agency’s inspectors. Test samples of medications taken by the facility’s inspectors who are investigating to see if the factory is ready to open for mass production – or investigate a possible problem. The employees also analyzed the products that were subject to consumer complaints.
Dr. Namandji N. Bombus, Deputy Commissioner who left the agency in December: “Laboratory scientists in the FDA (FDA) are very important for the agency’s tissue.”
The employees who monitored the safety of the drug and its effectiveness were also demobilized in a laboratory in San Juan, Puerto Rico, who specialize in assessing eye drops, nasal sprays and drugs that are managed with a patch on the skin.
Possible delays in cheaper drugs and on
Through the Food and Drug Administration (FDA), offices containing the term “policy” in the title of the judiciary were targeted. Although the work seems trivial on paper, it was especially important in the world of very disputed public drugs – which represents about 90 percent of the drugs used in the United States.
The employees of the General Narcotics Policy Office have done a strenuous work in the current law, or the provisions of the constantly changing court and scientific data to determine the drugs that can be approved as public or, in the event of biologically active treatments, such as Biosimilars. (BIOSIMILARS is drugs that are biologically with biologically active brands.)
These approvals provide consumers collectively. The demobilization operations of the general drug policy team can delay these savings.
John Murphy III, President of the Association of Medicines, which is accessible, which represents public pharmaceutical makers, said in a statement that he has supported efficiency efforts to obtain medicines for patients faster, but “it seems that many of the reported discounts are doing the opposite.”
Some of the bird influenza
The employees of the manager’s office at the Veterinary Medicine Center were rejected, which led to some work to respond to bird flu. The office had studied how to kill the pasteurus, bird flu in milk. He was also investigating the transmission of soft flu from raw pets to pets and was running the products of the products.
Scientists at the Veterinary Office were also helping the United States Agriculture Department Suggestions to develop Vaccines and treatments for poultry and animals aimed at fighting the virus and reducing egg prices.
Loss of monitoring of misleading ads
Mr. Kennedy sharply criticized televised drug ads. But his new hairstyles folded the section that monitors them for wrong or misleading claims. The office received complaints from the public and issued warning messages to companies that submit problematic claims. Although pharmaceutical companies have passed on employee discounts, this change can be considered as a victory.
“You must love the FDA,” said Adrian Vogue Berman, a professor of pharmacology at the Georgetown University Medical Center, in an email. “The Trump administration destroys a decisive agency for public health.”
adxpro.online